Mangoceuticals, Inc.

As of May 29, 2025, the market trend is mildly bearish, influenced by mixed indicators such as a mildly bullish weekly MACD, bearish moving averages, and a bearish KST, suggesting a cautious approach.

Mangoceuticals, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $5 million as of March 2025, with a market cap of $20.65 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -55.20%.

As of Jun 18, Mangoceuticals, Inc. has a market capitalization of 20.65 million, with net sales of 0.51 million and a net profit of -11.18 million over the last four quarters. The company's shareholder's funds are 15.10 million, and total assets are 16.52 million as of Dec 24.